The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levi-Schaffer, F.
Right arrow Articles by Zilberman, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levi-Schaffer, F.
Right arrow Articles by Zilberman, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HISTAMINE
The Journal of Immunology, 1998, 160: 5554-5562.
Copyright © 1998 by The American Association of Immunologists

Mast Cells Enhance Eosinophil Survival In Vitro: Role of TNF-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor1

Francesca Levi-Schaffer2,*,{dagger}, Vladislav Temkin*, Vivian Malamud*, Sari Feld* and Yael Zilberman*

* Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel; and {dagger} David R. Bloom Center of Pharmacy

Mast cell-eosinophil interactions in allergy have not yet been completely defined. To determine whether mast cells influence eosinophil survival, human peripheral blood eosinophils were incubated with rat peritoneal mast cell sonicate. After 3 days, viable eosinophils in medium were 21.3% compared with 44% with mast cell sonicate. Like sonicate, supernatants of compound 48/80-activated mast cells enhanced eosinophil survival, demonstrating that the factor(s) involved is stored preformed and rapidly released. Increased eosinophil survival was due to an inhibition of apoptosis (morphologic analysis; annexin V/PI). Neutralizing Abs to granulocyte-macrophage CSF (GM-CSF), but not to IL-3 or IL-5, decreased by 61.7% the enhancing effect on eosinophil viability. Eosinophils are the source of GM-CSF since its release in the culture medium was inhibited by their incubation with the mast cell sonicate together with dexamethasone. In addition, eosinophils incubated with the sonicate expressed mRNA for GM-CSF. To partially characterize the mast cell-derived factor(s) increasing eosinophil survival, the sonicate was heated (56°C/30 min or 100°C/10 min) or preincubated with antihistamines or with anti-TNF-{alpha}-neutralizing Abs. Most of the activity was heat labile. TNF-{alpha} was found to be predominantly (70%) responsible, while histamine had no role. Mast cell sonicate also caused eosinophils to release eosinophil peroxidase and to display morphologic signs of activation. In conclusion, we have demonstrated that mast cells enhance eosinophil survival in part through their activation to produce and release the autocrine survival cytokine GM-CSF.




This article has been cited by other articles:


Home page
Eur Respir JHome page
B. L. Bennett
c-Jun N-terminal kinase-dependent mechanisms in respiratory disease.
Eur. Respir. J., September 1, 2006; 28(3): 651 - 661.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Kinoshita, M. Okada, M. Hara, Y. Furukawa, and A. Matsumori
Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1858 - 1863.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Steffel, A. Akhmedov, H. Greutert, T. F. Luscher, and F. C. Tanner
Histamine Induces Tissue Factor Expression: Implications for Acute Coronary Syndromes
Circulation, July 19, 2005; 112(3): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Matsumoto, M. Terakawa, K. Miura, S. Fukuda, T. Nakajima, and H. Saito
Extremely Rapid and Intense Induction of Apoptosis in Human Eosinophils by Anti-CD30 Antibody Treatment In Vitro
J. Immunol., February 15, 2004; 172(4): 2186 - 2193.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Esnault and J. S. Malter
Hyaluronic Acid or TNF-{alpha} Plus Fibronectin Triggers Granulocyte Macrophage-Colony-Stimulating Factor mRNA Stabilization in Eosinophils Yet Engages Differential Intracellular Pathways and mRNA Binding Proteins
J. Immunol., December 15, 2003; 171(12): 6780 - 6787.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. Raqib, P. K. Moly, P. Sarker, F. Qadri, N. H. Alam, M. Mathan, and J. Andersson
Persistence of Mucosal Mast Cells and Eosinophils in Shigella-Infected Children
Infect. Immun., May 1, 2003; 71(5): 2684 - 2692.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Temkin, B. Kantor, V. Weg, M.-L. Hartman, and F. Levi-Schaffer
Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release
J. Immunol., September 1, 2002; 169(5): 2662 - 2669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Esnault and J. S. Malter
Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils
Blood, May 13, 2002; 99(11): 4048 - 4052.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. E. Capowski, S. Esnault, S. Bhattacharya, and J. S. Malter
Y Box-Binding Factor Promotes Eosinophil Survival by Stabilizing Granulocyte-Macrophage Colony-Stimulating Factor mRNA
J. Immunol., November 15, 2001; 167(10): 5970 - 5976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Esnault and J. S. Malter
Granulocyte Macrophage-Colony-Stimulating Factor mRNA Is Stabilized in Airway Eosinophils and Peripheral Blood Eosinophils Activated by TNF-{{alpha}} Plus Fibronectin
J. Immunol., April 1, 2001; 166(7): 4658 - 4663.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-L. Hartman, A. M. Piliponsky, V. Temkin, and F. Levi-Schaffer
Human peripheral blood eosinophils express stem cell factor
Blood, February 15, 2001; 97(4): 1086 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N. Saita, T. Yamanaka, H. Kohrogi, M. Ando, and M. Hirashima
Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Eur. Respir. J., February 1, 2001; 17(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-U. Simon, M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
J. Immunol., October 1, 2000; 165(7): 4069 - 4075.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Levi-Schaffer, E. Garbuzenko, A. Rubin, R. Reich, D. Pickholz, P. Gillery, H. Emonard, A. Nagler, and F. A. X. Maquart
Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor beta (TGF-beta )
PNAS, August 17, 1999; 96(17): 9660 - 9665.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.